Showing results (321-330 of 445) with videos related to

Sort By:
Pageof 45
JAMA Network Open|March 29, 2024
Trends in Adolescent Suicide by Method in the US, 1999-2020Cameron K Ormiston, Wayne R Lawrence, Saanie Sulley, et al.
The Medical Journal of Australia|September 26, 2023
Psychosocial outcomes and health service use after notifying women participating in population breast screening when they have dense breasts: a BreastScreen Queensland randomised controlled trialBrooke Nickel, Nick Ormiston-Smith, Lisa Hammerton, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 30, 2014
A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trialKenji Sakata, Bon-Kwon Koo, Katsuhisa Waseda, et al.
Plos One|March 22, 2014
Transcript analysis reveals a specific HOX signature associated with positional identity of human endothelial cellsMark Toshner, Benjamin J Dunmore, Eoin F McKinney, et al.
JACC. Cardiovascular Interventions|January 15, 2011
Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the "TAXUS Woman" analysisGhada W Mikhail, Robert T Gerber, David A Cox, et al.
Circulation. Cardiovascular Interventions|March 10, 2011
Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesionsHiromasa Otake, Yasuhiro Honda, Brian K Courtney, et al.
Journal of the American College of Cardiology|November 5, 2017
Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB TrialsGregg W Stone, Alexandre Abizaid, Yoshinobu Onuma, et al.
JACC. Cardiovascular Interventions|May 26, 2009
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trialBernard Chevalier, Carlo Di Mario, Franz-Josef Neumann, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Long-term paclitaxel-eluting stent outcomes in elderly patientsDaniel E Forman, David A Cox, Stephen G Ellis, et al.
The International Journal of Cardiovascular Imaging|January 8, 2011
Morphological and functional evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS, echogenicity and vasomotion testing at two year follow-up: a patient level insight into the ABSORB A clinical trialGiovanna Sarno, Nico Bruining, Yoshinobu Onuma, et al.
Pageof 45